BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 11439328)

  • 1. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis.
    von Lindern M; Deiner EM; Dolznig H; Parren-Van Amelsvoort M; Hayman MJ; Mullner EW; Beug H
    Oncogene; 2001 Jun; 20(28):3651-64. PubMed ID: 11439328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel way to induce erythroid progenitor self renewal: cooperation of c-Kit with the erythropoietin receptor.
    Wessely O; Bauer A; Quang CT; Deiner EM; von Lindern M; Mellitzer G; Steinlein P; Ghysdael J; Beug H
    Biol Chem; 1999 Feb; 380(2):187-202. PubMed ID: 10195426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of c-Kit and erythropoietin receptor in erythropoiesis.
    Munugalavadla V; Kapur R
    Crit Rev Oncol Hematol; 2005 Apr; 54(1):63-75. PubMed ID: 15780908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
    Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
    EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles of the receptor tyrosine kinases c-ErbB and c-Kit in regulating the balance between erythroid cell proliferation and differentiation.
    Wessely O; Mellitzer G; von Lindern M; Levitzki A; Gazit A; Ischenko I; Hayman MJ; Beug H
    Cell Growth Differ; 1997 May; 8(5):481-93. PubMed ID: 9149900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of erythroid progenitors by viral and cellular tyrosine kinases.
    Beug H; Schroeder C; Wessely O; Deiner E; Meyer S; Ischenko ID; Hayman MJ
    Cell Growth Differ; 1995 Aug; 6(8):999-1008. PubMed ID: 8547228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
    EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the erythropoietin and stem-cell-factor receptors.
    Wu H; Klingmüller U; Besmer P; Lodish HF
    Nature; 1995 Sep; 377(6546):242-6. PubMed ID: 7545788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells.
    Sivertsen EA; Hystad ME; Gutzkow KB; Døsen G; Smeland EB; Blomhoff HK; Myklebust JH
    Br J Haematol; 2006 Oct; 135(1):117-28. PubMed ID: 16965383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
    Danielsen AJ; Maihle NJ
    Exp Cell Res; 2002 Apr; 275(1):9-16. PubMed ID: 11925101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
    Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
    Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired erythropoiesis after haemorrhagic shock in mice is associated with erythroid progenitor apoptosis in vivo.
    Robinson Y; Matenov A; Tschöke SK; Weimann A; Oberholzer A; Ertel W; Hostmann A
    Acta Anaesthesiol Scand; 2008 May; 52(5):605-13. PubMed ID: 18419713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
    Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
    J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling pathways implicated in hematopoietic progenitor cell proliferation and differentiation.
    Bugarski D; Krstic A; Mojsilovic S; Vlaski M; Petakov M; Jovcic G; Stojanovic N; Milenkovic P
    Exp Biol Med (Maywood); 2007 Jan; 232(1):156-63. PubMed ID: 17202596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of early erythroid precursor cells (BFU-E) by a recombinant murine retrovirus containing v-erb-B.
    Miller M; Kennewell A; Takayama Y; Bruskin A; Bishop JM; Johnson G; Symonds G
    Oncogene; 1990 Aug; 5(8):1125-31. PubMed ID: 2168027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
    Schroeder C; Gibson L; Zenke M; Beug H
    Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The v-erb A oncogene causes repression of erythrocyte-specific genes and an immature, aberrant differentiation phenotype in normal erythroid progenitors.
    Schroeder C; Raynoschek C; Fuhrmann U; Damm K; Vennström B; Beug H
    Oncogene; 1990 Oct; 5(10):1445-53. PubMed ID: 1979159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.
    Schroeder C; Gibson L; Beug H
    Oncogene; 1992 Feb; 7(2):203-16. PubMed ID: 1347913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis.
    Menon MP; Karur V; Bogacheva O; Bogachev O; Cuetara B; Wojchowski DM
    J Clin Invest; 2006 Mar; 116(3):683-94. PubMed ID: 16511603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.